Welcome
Which of the following affects more than 25% of women over the age of 12?
A. Diabetes
B. Breast cancer
C. Osteoporosis
D. Herpes
D. Herpes. Approximately ONE out of FOUR women in the United States has genital herpes. Symptoms are often subtle, and most people don't know they have herpes, but genital herpes is among the most common infectious diseases. This is why the National Institute of Allergy and Infectious Diseases has joined forces with GlaxoSmithKline Biologicals to develop the Herpevac Trial for Women.
The Herpevac Trial for Women is investigating a promising vaccine to protect women against genital herpes, an infection that hundreds of thousands of women acquire each year.
With more than 40 trial sites in the United States and Canada, we welcome you to learn more about how the Herpevac Trial for Women may protect you and women everywhere against genital herpes!
|
